| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |